Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Asset disposition
Appointed director
CTI BIOPHARMA CORP (CTI) Create: Alert

All | News | Filings
Date FiledTypeDescription
03/11/2022 3 Fong James K (See Remarks) has filed a Form 3 on CTI BIOPHARMA CORP
09/03/2021 3 Parks Diane L. (Director) has filed a Form 3 on CTI BIOPHARMA CORP
03/10/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
03/04/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
08/03/2017 3 KIRSKE DAVID (See Remarks) has filed a Form 3 on CTI BIOPHARMA CORP
07/25/2017 3 Fischer Laurent (Director) has filed a Form 3 on CTI BIOPHARMA CORP
06/09/2017 3 ORBIMED ADVISORS LLC (10% Owner) has filed a Form 3 on CTI BIOPHARMA CORP
06/07/2017 3 Parkinson David Ross (Director) has filed a Form 3 on CTI BIOPHARMA CORP
03/21/2017 3 Craig Adam R (See Remarks) has filed a Form 3 on CTI BIOPHARMA CORP
01/24/2017 3 Metzger Michael A (Director) has filed a Form 3 on CTI BIOPHARMA CORP
09/07/2012 3 Plunkett Matthew (EVP, Corporate Development) has filed a Form 3 on CELL THERAPEUTICS INC
06/15/2012 3 BENNER STEVEN E (EVP, Chief Medical Officer) has filed a Form 3 on CELL THERAPEUTICS INC
09/26/2011 3 Tuckson Reed Vaughn (Director) has filed a Form 3 on CELL THERAPEUTICS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy